Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00393848 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery

A Phase 2 study of Osteoarthritis and Hip Fracture, sponsored by University of Arkansas.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT00393848: Completed Phase 2 study of Osteoarthritis and Hip Fracture, sponsored by University of Arkansas.

NCT00393848 is a Phase 2 study of Osteoarthritis and Hip Fracture that has completed, run by University of Arkansas. The registered enrollment target is 40 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00393848, a Phase 2 study of Osteoarthritis and Hip Fracture, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of two postoperative interventions designed to preserve muscle protein after major hip or knee surgery.

Interventions

  • DRUG Placebo
  • DRUG Ketoconazole
  • DRUG Essential amino acid supplement

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-10
Est. Completion 2012-10
Phase Phase 2
University of Arkansas

318 total trials

What the finished NCT00393848 record still lists

NCT00393848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00393848 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT00393848 about?

NCT00393848 is a clinical study titled "Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery". The purpose of this study is to determine the effects of two postoperative interventions designed to preserve muscle protein after major hip or knee surgery.

What is the current status of trial NCT00393848?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2006-10. Estimated completion is 2012-10.

What conditions does trial NCT00393848 study?

This clinical trial studies the following conditions: Osteoarthritis, Hip Fracture, Femur Head Necrosis.

What interventions are being tested in trial NCT00393848?

The interventions under investigation include: Placebo (DRUG), Ketoconazole (DRUG), Essential amino acid supplement (DRUG).

Who is sponsoring clinical trial NCT00393848?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00393848 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00393848's enrollment target sits among peer trials

40 121st of 135 higher than 11 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00393848, the US trial registry maintained by the National Library of Medicine. NCT00393848 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.